The positive inotropic effect of angiotensin II: Role of endothelin-1 and reactive oxygen species

Hypertension

Volumn 47, Issue 4, 2006, Pages 727-734

  Cingolani, Horacio E ^a   Villa Abrille, María C ^a   Cornelli, Mariana ^a   Nolly, Alejandro ^a   Ennis, Irene L ^a   Garciarena, Carolina ^a   Suburo, Angela M ^b   Torbidoni, Vanesa ^b   Correa, María V ^a   Camilión De Hurtado, María C ^a   Aiello, Ernesto A ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSIDAD AUSTRAL   (Argentina)

Author keywords

Ion channels; Membranes; Oxidative stress; Receptors, angiotensin

Indexed keywords

ANGIOTENSIN II; BIG ENDOTHELIN 1; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; MESSENGER RNA; PREPROENDOTHELIN 1; REACTIVE OXYGEN METABOLITE; SCAVENGER; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM PROTON EXCHANGE PROTEIN; TAK 044; TIOPRONIN; CARDIOTONIC AGENT;

ANIMAL CELL; ARTICLE; CAT; CONTROLLED STUDY; EPIFLUORESCENCE MICROSCOPY; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; INOTROPISM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMERE; ANIMAL; DRUG EFFECT; HEART CONTRACTION; METABOLISM; METHODOLOGY; PHYSIOLOGY; STAINING;

ANGIOTENSIN II; ANIMALS; CARDIOTONIC AGENTS; CATS; ENDOTHELIN-1; IMMUNOHISTOCHEMISTRY; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; REACTIVE OXYGEN SPECIES; RECEPTOR, ENDOTHELIN A; SARCOMERES; SODIUM-HYDROGEN ANTIPORTER; STAINING AND LABELING;

EID: 33645822732     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000208302.62399.68     Document Type: Article

References (37)

1. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, Nogami A, Murumo F, Hiroe M. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest. 1993;92:398-403.
2. Liang F, Gardner DG. Autocrine/paracrine determinants of strain-activated brain natriuretic peptide gene expression in cultured cardiac myocytes. J Biol Chem. 1998;273:14612-14619.
3. Rajagopalan S, Laursen JB, Borthayre A, Kurz S, Keiser J, Haleen S, Giaid A, Harrison DG. Role for endothelin-1 in angiotensin II-mediated hypertension. Hypertension. 1997;30:29-34.
4. Ortiz MC, Sanabria E, Manriquez MC, Romero JC, Juncos LA. Role of endothelin and isoprostanes in slow pressor responses to angiotensin II. Hypertension. 2001;37:505-510.
5. Lavigne MC, Malech HL, Holland SM, Leto TL. Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation. 2001;104:79-84.
6. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest. 2005;115:500-508.
7. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, Suzuki T, Maeta H, Abe Y. Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension. 2005;45:860-866.
8. Hong HJ, Chan P, Liu JC, Juan SH, Huang MT, Lin JG, Cheng TH. Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. Cardiovasc Res. 2004;61:159-168.
9. Li L, Fink GD, Watts SW, Northcott CA, Galligan JJ, Pagano PJ, Chen AF. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation. 2003;107:1053-1058.
10. Callera GE, Touyz RM, Teixeira SA, Muscara MN, Carvalho MH, Fortes ZB, Nigro D, Schiffrin EL, Tostes RC. ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension. Hypertension. 2003;42:811-817.
11. Sand C, Peters SL, Pfaffendorf M, van Zwieten PA. The influence of endogenously generated reactive oxygen species on the inotropic and chronotropic effects of adrenoceptor and ET-receptor stimulation. Naunyn Schmiedebergs Arch Pharmacol. 2003;367:635-639.
12. 2+ and protein kinase C-dependent mechanism. Am J Physiol. 2001;280:H1528-H1536.
13. Ennis IL, Garciarena CD, Perez NG, Dulce RA, Camilion de Hurtado MC, Cingolani HE. Endothelin isoforms and the response to myocardial stretch. Am J Physiol. 2005;288:H2925-H2930.
14. Keller A, Mohamed A, Drose S, Brandt U, Fleming I, Brandes RP. Analysis of dichlorodihydrofluorescein and dihydrocalcein as probes for the detection of intracellular reactive oxygen species. Free Radic Res. 2004;38:1257-1267.
15. Torbidoni V, Iribarne M, Ogawa L, Prasanna G, Suburo AM. Endothelin-1 and endothelin receptors in light-induced retinal degeneration. Exp Eye Res. 2005;81:265-275.
16. Hobai IA, O'Rourke B. The potential of Na+/Ca2+ exchange blockers in the treatment of cardiac disease. Expert Opin Investig Drugs. 2004;13:653-664.
17. Watano T, Kimura J, Morita T, Nakanishi H. A novel antagonist, No. 7943, of the Na+/Ca2+ exchange current in guinea-pig cardiac ventricular cells. Br J Pharmacol. 1996;119:555-563.
18. 2+ exchange by endothelin release. Cardiovasc Res. 2003;60:589-597.
19. Preisig-Muller R, Mederos y Schnitzler M, Derst C, Daut J. Separation of cardiomyocytes and coronary endothelial cells for cell-specific RT-PCR. Am J Physiol. 1999;277:H413-H416.
20. Shohet RV, Kisanuki YY, Zhao XS, Siddiquee Z, Franco F, Yanagisawa M. Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy. Proc Natl Acad Sci U S A. 2004;101:2088-2093.
21. Takano H, Tang XL, Qiu Y, Guo Y, French BA, Bolli R. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res. 1998;83:73-84.
22. Tanonaka K, Iwai T, Motegi K, Takeo S. Effects of N-(2-mercaptopropyonil) -glycine on mitochondrial function in ischemic-reperfused heart. Cardiovasc Res. 2003;57:416-425.
23. Xia Y, Karmazyn M. Obligatory role for endogenous endothelin in mediating the hypertrophic effects of phenylephrine and angiotensin II in neonatal rat ventricular myocytes: evidence for two distinct mechanisms for endothelin regulation. J Pharmacol Exp Ther. 2004;310:43-51.
24. Petroff MG, Aiello EA, Palomeque J, Salas MA, Mattiazzi A. Subcellular mechanisms of the positive inotropic effect of angiotensin II in cat myocardium. J Physiol. 2000;529:189-203.
25. Freer RJ, Pappano AJ, Peach MJ, Bing KT, McLean MJ, Vogel S, Sperelakis N. Mechanism for the postive inotropic effect of angiotensin II on isolated cardiac muscle. Circ Res. 1976;39:178-183.
26. Ichiyanagi O, Ishii K, Endoh M. Angiotensin II increases L-type Ca2+ current in gramicidin D-perforated adult rabbit ventricular myocytes: comparison with conventional patch-clamp method. Pflugers Arch. 2002;444:107-116.
27. Dell'Italia LJ, Meng QC, Balcells E, Wei CC, Palmer R, Hageman GR, Durand J, Hankes GH, Oparil S. Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces. J Clin Invest. 1997;100:253-258.
28. Palomeque J, Sapia L, Hajjar RJ, Mattiazzi A, Vila Petroff MG. Agiotensin II-induced negative inotropy in rat ventricular myocytes: Role of reactive oxygen species and p38 MAPK. Am J Physiol. 2006;290:H96-H106.
29. Delbridge LM, Morgan TO, Harris PJ. Effects of endothelin-1 on the contractility of cardiomyocytes from the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol. 1995;22:755-762.
30. Kedziersld RM, Graybum PA, Kisanuki YY, Williams CS, Hammer RE, Richardson JA, Schneider MD, Yanagisawa M. Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol. Mol Cell Biol. 2003;23:8226-8232.
31. Camilion de Hurtado MC, Alvarez BV, Perez NG, Ennis IL, Cingolani HE. Angiotensin II activates Na+-independent C1-HCO3- exchange in ventricular myocardium. Circ Res. 1998;82:473-481.
32. Luers C, Fialka F, Elgner A, Zhu D, Kockskamper J, von Lewinski D, Pieske B. Stretch-dependent modulation of [Na+]i, [Ca2+]i, and pHi in rabbit myocardium-a mechanism for the slow force response. Cardiovasc Res. 2005;68:454-463.
33. Li L, Galligan JJ, Fink GD, Chen AF. Vasopressin induces vascular superoxide via endothelin-1 in mineralocorticoid hypertension. Hypertension. 2003;41:663-668.
34. Ortiz MC, Manriquez MC, Romero JC, Juncos LA. Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension. 2001;38:655-659.
35. Touyz RM, Yao G, Viel E, Amiri F, Schiffrin EL. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J Hypertens. 2004;22:1141-1149.
36. Wettschureck N, Rutten H, Zywietz A, Gehring D, Wilkie TM, Chen J, Chien KR, Offermanns S. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes. Nat Med. 2001;7:1236-1240.
37. Cingolani HE, Pérez NG, Aiello EA, Camilión de Hurtado MC. Intracellular signaling following myocardial stretch: An autocrine/paracrine loop. Regulatory Peptides. 2005;128:211-220.